Tauroursodeoxycholate protects from glycochenodeoxycholate-induced gene expression changes in perfused rat liver
- PMID: 31152635
- DOI: 10.1515/hsz-2019-0204
Tauroursodeoxycholate protects from glycochenodeoxycholate-induced gene expression changes in perfused rat liver
Abstract
Tauroursodeoxycholate (TUDC) is well known to protect against glycochenodeoxycholate (GCDC)-induced apoptosis in rat hepatocytes. In the present study, we analyzed whether TUDC also exerts protective effects by modulating GCDC-induced gene expression changes. For this, gene array-based transcriptome analysis and quantitative polymerase chain reaction (qPCR) were performed on RNA isolated from rat livers perfused with GCDC, TUDC or a combination of both (each 20 μm for 2 h). GCDC led to a significant increase of lactate dehydrogenase (LDH) into the effluent perfusate, which was prevented by TUDC. GCDC, TUDC and co-perfusion induced distinct gene expression changes. While GCDC upregulated the expression of several pro-inflammatory genes, co-perfusion with TUDC increased the expression of pro-proliferative and anti-apoptotic p53 target genes. In line with this, levels of serine20-phosphorylated p53 and of its target gene p21 were elevated by GCDC in a TUDC-sensitive way. GCDC upregulated the oxidative stress surrogate marker 8OH(d)G and the pro-apoptotic microRNAs miR-15b/16 and these effects were prevented by TUDC. The upregulation of miR-15b and miR-16 in GCDC-perfused livers was accompanied by a downregulation of several potential miR-15b and miR-16 target genes. The present study identified changes in the transcriptome of the rat liver which suggest, that TUDC is hepatoprotective by counteracting GCDC-induced gene expression changes.
Keywords: GCDC; TUDC; liver protection; miRNA; β1-integrin.
References
-
- Becker, S., Reinehr, R., Graf, D., Vom Dahl, S., and Häussinger, D. (2007). Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. Cell. Physiol. Biochem. 19, 89–98.
-
- Belguise, K., Kersual, N., Galtier, F., and Chalbos, D. (2005). FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24, 1434–1444.
-
- Benes, V., Collier, P., Kordes, C., Stolte, J., Rausch, T., Muckentaler, M.U., Häussinger, D., and Castoldi, M. (2015). Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci. Rep. 5, 11590.
-
- Beuers, U. (2006). Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 318–328.
-
- Beuers, U., Spengler, U., Kruis, W., Aydemir, Ü., Wiebecke, B., Heldwein, W., Weinzierl, M., Pape, G.R., Sauerbruch, T., and Paumgartner, G. (1992). Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16, 707–714.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous